Vcanbio Cell & Gene Engineering Corp., Stock Forecast
Vcanbio Cell & Gene Engineering Corp., stock upgraded to Hold/Accumulate.
(Updated on Jun 21, 2024)
The Vcanbio Cell & Gene Engineering Corp., stock price gained 1.10% on the last trading day (Friday, 21st Jun 2024), rising from $16.38 to $16.56. During the last trading day the stock fluctuated 3.49% from a day low at $16.33 to a day high of $16.90. The price has risen in 6 of the last 10 days but is still down by -0.72% for this period. Volume fell on the last day by -627 thousand shares and in total, 4 million shares were bought and sold for approximately $65.22 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $16.40 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.37% during the next 3 months and, with a 90% probability hold a price between $17.45 and $23.99 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
600645.SS Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, June 20, 2024, and so far it has risen 1.10%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vcanbio Cell & Gene Engineering Corp., stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $16.71 and $17.83. A break-up above any of these levels will issue buy signals.
Support, Risk & Stop-loss for Vcanbio Cell & Gene Engineering Corp., stock
Vcanbio Cell & Gene Engineering Corp., finds support from accumulated volume at $16.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.570 between high and low, or 3.49%. For the last week, the stock has had daily average volatility of 2.93%.
Our recommended stop-loss: $15.63 (-5.60%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 30 days ago.)
Trading Expectations (600645.SS) For The Upcoming Trading Day Of Monday 24th
For the upcoming trading day on Monday, 24th we expect Vcanbio Cell & Gene Engineering Corp., Ltd to open at $16.60, and during the day (based on 14 day Average True Range), to move between $16.05 and $17.07, which gives a possible trading interval of +/-$0.505 (+/-3.05%) up or down from last closing price. If Vcanbio Cell & Gene Engineering Corp., Ltd takes out the full calculated possible swing range there will be an estimated 6.10% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $16.33 (1.39%) than the resistance at $18.69 (12.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Vcanbio Cell & Gene Engineering Corp., Ltd stock A Buy?
Vcanbio Cell & Gene Engineering Corp., holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.173 Hold/Accumulate Upgraded
Predicted Opening Price for Vcanbio Cell & Gene Engineering Corp., Ltd of Monday, June 24, 2024
| Fair opening price June 24, 2024 | Current price |
|---|---|
| $16.60 ( 0.221%) | $16.56 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 600645.SS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 17.17 | 3.66% |
| R2 | 16.95 | 2.35% |
| R1 | 16.81 | 1.54% |
| Price | 16.56 | |
| S1 | 16.38 | -1.09% |
| S2 | 16.24 | -1.91% |
| S3 | 16.03 | -3.22% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 20.18 | 21.86% |
| R2 | 19.09 | 15.28% |
| R1 | 18.69 | 12.86% |
| Price | 16.56 | |
| S1 | 16.33 | -1.39% |
| S2 | 15.91 | -3.93% |
| S3 | 15.09 | -8.88% |
600645 Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Aug 10, 2001 | Aug 10, 2001 | Aug 10, 2001 | $0.0059 | 0.0668% |
| 2 | Jul 06, 1998 | Jul 06, 1998 | Jul 06, 1998 | $0.0368 | 0.799% |
| 3 | Apr 25, 1995 | Apr 25, 1995 | Apr 25, 1995 | $0.0708 | 2.24% |
FAQ
Click here for our free guide on how to buy Vcanbio Cell & Gene Engineering Corp., Ltd Stock.
